Correlation Between Denali Therapeutics and Equillium

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Equillium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Equillium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Equillium, you can compare the effects of market volatilities on Denali Therapeutics and Equillium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Equillium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Equillium.

Diversification Opportunities for Denali Therapeutics and Equillium

DenaliEquilliumDiversified AwayDenaliEquilliumDiversified Away100%
-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between Denali and Equillium is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Equillium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Equillium and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Equillium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Equillium has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Equillium go up and down completely randomly.

Pair Corralation between Denali Therapeutics and Equillium

Given the investment horizon of 90 days Denali Therapeutics is expected to under-perform the Equillium. But the stock apears to be less risky and, when comparing its historical volatility, Denali Therapeutics is 2.86 times less risky than Equillium. The stock trades about -0.09 of its potential returns per unit of risk. The Equillium is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  68.00  in Equillium on November 25, 2024 and sell it today you would earn a total of  20.00  from holding Equillium or generate 29.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Denali Therapeutics  vs.  Equillium

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -30-20-100102030
JavaScript chart by amCharts 3.21.15DNLI EQ
       Timeline  
Denali Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Denali Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in March 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb1920212223242526
Equillium 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Equillium are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Equillium reported solid returns over the last few months and may actually be approaching a breakup point.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb0.50.60.70.80.91

Denali Therapeutics and Equillium Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-6.75-5.05-3.36-1.670.01.533.074.66.13 0.0100.0150.0200.025
JavaScript chart by amCharts 3.21.15DNLI EQ
       Returns  

Pair Trading with Denali Therapeutics and Equillium

The main advantage of trading using opposite Denali Therapeutics and Equillium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Equillium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will offset losses from the drop in Equillium's long position.
The idea behind Denali Therapeutics and Equillium pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities